These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29217142)

  • 1. Pharmacist-led depression screening and intervention in an underserved, rural, and multi-ethnic diabetic population.
    Wilson C; Twigg G
    J Am Pharm Assoc (2003); 2018; 58(2):205-209. PubMed ID: 29217142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, implementation, and evaluation of a pharmacist-conducted screening program for depression.
    Rosser S; Frede S; Conrad WF; Heaton PC
    J Am Pharm Assoc (2003); 2013; 53(1):22-9. PubMed ID: 23636152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing a pharmacist provided mental health screening service in a rural community to address anxiety and depression.
    Jewell TM; Kowalski A; Lahrman R
    J Am Pharm Assoc (2003); 2024; 64(4S):102103. PubMed ID: 38649094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
    Isho NY; Kachlic MD; Marcelo JC; Martin MT
    J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-initiated peripheral arterial disease screening program in a community pharmacy setting.
    Winfrey C; Wortman S; Frede S; Kunze N; Conrad WF; Heaton PC
    J Am Pharm Assoc (2003); 2011; 51(3):373-7. PubMed ID: 21555289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A feasibility study of community pharmacists performing depression screening services.
    O'Reilly CL; Wong E; Chen TF
    Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of community pharmacist-performed post-discharge medication reviews in transitions of care.
    Tetuan CE; Guthrie KD; Stoner SC; May JR; Hartwig DM; Liu Y
    J Am Pharm Assoc (2003); 2018; 58(6):659-666. PubMed ID: 30056133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient attitudes regarding pharmacist-administered memory screening in community pharmacies.
    Breslow RM
    J Am Pharm Assoc (2003); 2013; 53(6):648-51. PubMed ID: 24185433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an enhanced depression and anxiety screening with targeted pharmacist intervention.
    Reid S; Nichols R; Veach S; Alhersh E; Witry M
    J Am Pharm Assoc (2003); 2024; 64(3):102067. PubMed ID: 38490332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
    Krska J; Mackridge AJ
    Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an enhanced depression and anxiety screening with targeted pharmacist intervention.
    Reid S; Nichols R; Veach S; Alhersh E; Witry M
    J Am Pharm Assoc (2003); 2024; 64(4S):102180. PubMed ID: 39127944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone health screening, education, and referral project in northwest Iowa: creating a model for community pharmacies.
    Johnson JF; Koenigsfeld C; Hughell L; Parsa RA; Bravard S
    J Am Pharm Assoc (2003); 2008; 48(3):379-87. PubMed ID: 18595823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist screening for depression among patients with diabetes in an urban primary care setting.
    Knight DE; Draeger RW; Heaton PC; Patel NC
    J Am Pharm Assoc (2003); 2008; 48(4):518-21. PubMed ID: 18653429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient and prescriber perceptions of depression screening within a community pharmacy setting.
    Mospan CM; Gillette C; Wilson JA
    J Am Pharm Assoc (2003); 2020; 60(5S):S15-S22. PubMed ID: 32280022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Columbus Air Force Base medication profile intervention practice innovation.
    Guill JV; Griffin LA; Goodwin TD
    J Am Pharm Assoc (2003); 2008; 48(5):654-8. PubMed ID: 18826905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a depression screening as part of a holistic adherence assessment in a large community pharmacy chain.
    Zmoira A; Rogers E; Johnson A; Johnson K
    J Am Pharm Assoc (2003); 2021; 61(4S):S154-S160. PubMed ID: 33451969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting.
    Fuller L; Conrad WF; Heaton PC; Panos R; Eschenbacher W; Frede SM
    J Am Pharm Assoc (2003); 2012; 52(5):e59-66. PubMed ID: 22975798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.